A vs ACRS: Which Stock is Better?

Side-by-side comparison of Agilent Technologies Inc and Aclaris Therapeutics Inc in 2026

Comparison Updated:

A

Agilent Technologies Inc

$119.77

ACRS

Aclaris Therapeutics Inc

$3.93

Key Metrics Comparison

MetricAACRSWinner
Market Cap$34.05B$474.66MA
P/E Ratio25.89N/AA
EPS (TTM)$4.65$N/AA
Revenue Growth0.1%-0.9%A
Gross Margin52.3%-665.8%A

Analyze A

Full quant analysis

Analyze ACRS

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is A or ACRS a better investment?

Comparing A and ACRS: Agilent Technologies Inc has a market cap of $34.05B while Aclaris Therapeutics Inc has $474.66M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between A and ACRS?

A (Agilent Technologies Inc) and ACRS (Aclaris Therapeutics Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: A or ACRS?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: A or ACRS?

A has higher revenue growth at 0.1% vs -0.9% for ACRS.

Which company is more profitable: A or ACRS?

Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to -665.8% for ACRS.

Which is the larger company: A or ACRS?

Agilent Technologies Inc (A) is larger with a market cap of $34.05B compared to $474.66M for ACRS.

Should I buy A or ACRS in 2026?

Both A and ACRS have investment merit. A trades at $119.77 while ACRS trades at $3.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between A and ACRS stock?

Key differences: Market Cap ($34.05B vs $474.66M), P/E Ratio (25.9x vs N/A), Revenue Growth (0.1% vs -0.9%), Gross Margin (52.3% vs -665.8%).

Popular Stock Comparisons